J. M. Cruz-Fernández

发表

Efficacy and safety of ezetimibe co‐administered with ongoing atorvastatin therapy in achieving low‐density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease

J. Adgey, A. Johnson‐Levonas, J. M. Cruz-Fernández, 2005, International journal of clinical practice.

Randomized comparative trial of triflusal and aspirin following acute myocardial infarction.

A. Castro‐Beiras, D. Garcia-Dorado, J. M. Cruz-Fernández, 2000, European heart journal.

Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome.

D. Fernández-Bergés, V. Bertomeu-González, J. M. Cruz-Fernández, 2011, International journal of cardiology.

Influence of the previous use of β-blockers on the early clinical course of acute coronary syndromes

M. Almendro-Delia, R. Hidalgo-Urbano, J. Garcia-Rubira, 2015, Internal and Emergency Medicine.

[Valve repair for bicuspid aortic valve regurgitation: an option?].

P. Gallego, J. M. Barquero, J. M. Cruz-Fernández, 2007, Revista espanola de cardiologia.

Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina

V. Sánchez-Margalet, R. Goberna, J. Cubero, 2002, Clinical chemistry and laboratory medicine.

Antiplatelet drugs in the treatment of acute coronary syndromes: Focus on cyclooxygenase inhibitors

J. M. Cruz-Fernández, 2001 .

Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina.

J. Kaski, J. Cubero, J. M. Cruz-Fernández, 2007, International journal of cardiology.

Protective effect of triflusal against acute myocardial infarction in patients with unstable angina: results of a Spanish multicenter trial. Grupo de Estudio del Triflusal en la Angina Inestable.

E. Alegrı́a, Á. Artal, J. Ruipérez, 1993, Cardiology.

Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome.

J. Kaski, D. Fernández-Bergés, J. Marrugat, 2008, Atherosclerosis.

[Inflammation markers and risk stratification in patients with acute coronary syndromes: design of the SIESTA Study (Systemic Inflammation Evaluation in Patients with non-ST segment elevation Acute coronary syndromes)].

J. Kaski, D. Fernández-Bergés, J. M. Cruz-Fernández, 2003, Revista espanola de cardiologia.

Marcadores de inflamación y estratificación de riesgo en pacientes con síndrome coronario agudo: diseño del estudio SIESTA (Systemic Inflammation Evaluation in patients with non-ST segment elevation Acute coronary syndromes)

J. Kaski, D. Fernández-Bergés, J. M. Cruz-Fernández, 2003 .

The tobacco paradox in acute coronary syndrome. The prior cessation of smoking as a marker of a better short-term prognosis.

M. Almendro-Delia, R. Hidalgo-Urbano, J. Garcia-Rubira, 2016, Revista clinica espanola.

Expression of activation molecules in neutrophils, monocytes and lymphocytes from patients with unstable angina treated with stent implantation

V. Sánchez-Margalet, R. Goberna, J. M. Cruz-Fernández, 2004, Clinical Chemistry and Laboratory Medicine.

Functional anatomy of aortic regurgitation. Role of transesophageal echocardiography in aortic valve-sparing surgery.

O. Araji, J. M. Barquero, J. M. Cruz-Fernández, 2010, Revista espanola de cardiologia.

The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial

M. I. Santiago-Pérez, A. Castro‐Beiras, J. Muñiz, 2010, Health and quality of life outcomes.